An insight into the use of telemedicine technology for cancer patients during the Covid-19 pandemic: a scoping review
Background
The use of telemedicine technology has significantly increased in recent years, particularly during the Covid-19 pandemic. This study aimed to investigate the use of telemedicine technology for cancer patients during the Covid-19 pandemic.
Methods
This was a scoping review conducted in 2023. Various databases including PubMed, Web of Science, Scopus, Cochrane Library, Ovid, IEEE Xplore, ProQuest, Embase, and Google Scholar search engine were searched. All quantitative, qualitative, and mixed-method studies published in English between 2020 and 2022 were included. Finally, the needed data were extracted, and the results were synthesized and reported narratively.
Results
A total of 29 articles were included in this review. The results showed that teleconsultation, televisit, and telerehabilitation were common telemedicine services, and video conferencing and telephone were common technologies used in these studies. In most cases, patients and healthcare providers preferred these services compared to the face-to-face consultations due to their convenience and advantages. Furthermore, the findings revealed that in terms of clinical outcomes, telemedicine could effectively reduce anxiety, pain, sleep disorders, and hospital admission rates.
Conclusion
The findings provided valuable insights into the various telemedicine technologies, services, users’ perspectives, and clinical outcomes in cancer patients during the Covid-19 pandemic. Overall, the positive outcomes and users’ satisfaction showed that the use of telemedicine technology can be expanded, particularly in cancer care. Future research needs to investigate both clinical and non-clinical effectiveness of using various telemedicine services and technologies for improving cancer care delivery, which can help to develop more successful strategies for implementing this technology.
Top-30
Journals
|
1
|
|
|
Life Sciences
1 publication, 12.5%
|
|
|
Discover Medicine
1 publication, 12.5%
|
|
|
International Journal of Pharmaceutical and Healthcare Marketing
1 publication, 12.5%
|
|
|
Archives of Public Health
1 publication, 12.5%
|
|
|
Supportive Care in Cancer
1 publication, 12.5%
|
|
|
Frontiers in Public Health
1 publication, 12.5%
|
|
|
BMC Medical Education
1 publication, 12.5%
|
|
|
JMIR Cancer
1 publication, 12.5%
|
|
|
1
|
Publishers
|
1
2
3
4
|
|
|
Springer Nature
4 publications, 50%
|
|
|
Elsevier
1 publication, 12.5%
|
|
|
Emerald
1 publication, 12.5%
|
|
|
Frontiers Media S.A.
1 publication, 12.5%
|
|
|
JMIR Publications
1 publication, 12.5%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.